BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND ARID2, ENSG00000189079, 196528, Q68CP9, p200, KIAA1557, FLJ30619, DKFZp779P0222, DKFZp686G052, BAF200
7 results:

  • 1. Characterization of a Preclinical In Vitro Model Derived from a SMARCA4-Mutated Sinonasal Teratocarcinosarcoma.
    Lorenzo-Guerra SL; Codina-Martínez H; Suárez-Fernández L; Cabal VN; García-Marín R; Riobello C; Vivanco B; Blanco-Lorenzo V; Sánchez-Fernández P; López F; Llorente JL; Hermsen MA
    Cells; 2023 Dec; 13(1):. PubMed ID: 38201285
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Competitive evolved sub-clonal BCR::ABL1 and novel MSI2::PC fusion genes in myelodysplastic syndrome with isolated del(5q).
    Zhang Y; Liu Y; Wang T; Wang H; Chen X; Cao P; Ma X; Liu M; Xu P; Bi H; Pan J; Jiang Y; Li X; Wang W; Liu H
    Hematol Oncol; 2023 Feb; 41(1):178-181. PubMed ID: 36301018
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia.
    Fabiani E; Cicconi L; Nardozza AM; Cristiano A; Rossi M; Ottone T; Falconi G; Divona M; Testi AM; Annibali O; Castelli R; Lazarevic V; Rego E; Montesinos P; Esteve J; Venditti A; Della Porta M; Arcese W; Lo-Coco F; Voso MT
    Cancer Med; 2021 Jun; 10(12):3839-3847. PubMed ID: 34042280
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis.
    Hill HA; Qi X; Jain P; Nomie K; Wang Y; Zhou S; Wang ML
    Blood Adv; 2020 Jul; 4(13):2927-2938. PubMed ID: 32598477
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pbrm1 Steers Mesenchymal Stromal Cell Osteolineage Differentiation by Integrating PBAF-Dependent Chromatin Remodeling and BMP/TGF-β Signaling.
    Sinha S; Biswas M; Chatterjee SS; Kumar S; Sengupta A
    Cell Rep; 2020 Apr; 31(4):107570. PubMed ID: 32348751
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Neutrophil elastase-mediated proteolysis of the tumor suppressor p200 CUX1 promotes cell proliferation and inhibits cell differentiation in APL.
    Yu L; Zhong L; Xiong L; Dan W; Li J; Ye J; Wan P; Luo X; Chu X; Liu C; He C; Mu F; Liu B
    Life Sci; 2020 Feb; 242():117229. PubMed ID: 31887298
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. IFI16 inhibits tumorigenicity and cell proliferation of bone and cartilage tumor cells.
    Zhang Y; Howell RD; Alfonso DT; Yu J; Kong L; Wittig JC; Liu CJ
    Front Biosci; 2007 Sep; 12():4855-63. PubMed ID: 17569615
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.